Skip to main content
. Author manuscript; available in PMC: 2015 Jan 26.
Published in final edited form as: Clin Lung Cancer. 2010 Nov 1;11(6):405–411. doi: 10.3816/CLC.2010.n.052

Figure 1. Growth Inhibition of 5-Azacytidine on Human NSCLC Cell Lines.

Figure 1

H226, H358, and H460 cells were treated with (5-fold) increasing concentrations of 5-Aza. The percentage of growth inhibition was measured with MTT Assay. The data for each cell line are mean ± standard deviation obtained from 3 independent experiments.

Abbreviations: 5-Aza = 5-azacytidine; NSCLC = non–small-cell lung cancer